Researchers combined protein biomarkers, cfDNA analysis, and machine learning to open opportunities for early-stage ovarian cancer screening and diagnostics. The cfDNA fragmentome is a genome-wide ...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the publication in npj ...
For women, ovarian cancer is one of the most feared of all diagnoses. Sneaking up silently, often with few symptoms, the ...
6don MSNOpinion
National genomic screening program could save thousands of Australians from preventable cancer and heart disease
Leading genomic health experts from Monash University are calling for urgent government funding to progress the development ...
The government urges wider HPV vaccination and DNA-based screening to cut cervical cancer rates and improve early detection.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback